Eluforsen is under investigation in clinical trial NCT02532764 (Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.